COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19) : COLCHICINE CORONAVIRUS SARS-CoV2 TRIAL - COLCORONA
| Medienart: |
|
|---|
Klinische Studie| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
WHO International Clinical Trials Registry Platform - (2021) vom: 10. Aug. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Unbestimmt |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-10-2020, Last updated: 2022-11-24 |
|---|
| ICTRP ID: |
EUCTR2020-001689-12-GR |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
CTG005801494 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | CTG005801494 | ||
| 003 | DE-627 | ||
| 005 | 20230425183729.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210507s2021 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)CTG005801494 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)EUCTR2020-001689-12-GR | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)MHIPS-2020-001 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)NCT04322682 | ||
| 035 | |a (UBBS_Klinische_Studien_WHO)2020-001689-12-ES | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a und | ||
| 245 | 1 | 0 | |a COLCHICINE STUDY IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19) |b COLCHICINE CORONAVIRUS SARS-CoV2 TRIAL - COLCORONA |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 19-10-2020, Last updated: 2022-11-24 | ||
| 650 | 4 | |a Medical Condition: COVID-19 MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | |
| 650 | 4 | |a Study Type: Interventional | |
| 650 | 4 | |a Phase: Phase 3 | |
| 650 | 4 | |a Recruitment Status: Not yet recruiting | |
| 650 | 4 | |a 610 | |
| 773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2021) vom: 10. Aug. |
| 773 | 1 | 8 | |g year:2021 |g day:10 |g month:08 |
| 856 | 4 | 0 | |u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12 |z kostenfrei |3 Volltext |
| 912 | |a GBV_CTG | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 10 |c 08 | ||